#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Internal Medicine - Issue 4/2015

Reviews

291

The position of new antidiabetics in clinical practice: SGLT2 vs DPP4 inhibitors

Jan Šoupal, Martin Prázný

301

Biosimilar insulines – new possibilities of diabetes treatment

Jan Škrha

304

The treatment of diabetes in patients with liver and renal impairment

Martin Haluzík

312

Possibilities of therapy GLP1 RA for diabetics with nephropathy

Alena Adamíková

316

Treatment of GLP1 receptor agonists and body mass control

Petr Žák, Jindřich Olšovský

321

Treatment of an elderly patients with diabetes

Zdeněk Rušavý, Michal Žourek

328

Issues of infection related to diabetic foot syndrome

MUDr. Milan Flekač, Ph.D.

335

Treatment of hypertension in diabetes mellitus

Jiří Widimský Jr

340

Physical activity in patients with microvascular complications of diabetes

Martin Matoulek

355

Progress in the development of insulin pumps and their advanced automatic functions

Martin Prázný

361

The microbial flora in the digestive tract and diabetes

Štěpán Svačina

365

Myokines – muscle tissue hormones

Zuzana Stránská, Štěpán Svačina

Original Contributions

295

Do diabetologists choose a therapy rationally?
Basic results of the PROROK project (A prospective observation project to assess the relevance of the difference between fasting glycemia and postprandial glycemia to estimation of success of type 2 diabetes therapy)

Denisa Janíčková Žďárská, Pavlína Piťhová, Tomáš Pavlík, Milan Kvapil

346

Glycation of lens proteins in diabetes and its non-invasive assessment – first experience in the Czech Republic

Jan Škrha Jr, Jan Šoupal, Martin Prázný, Jan Škrha

351

miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?

Pavel Škrha, Aleš Hořínek, Michal Anděl, Jan Škrha

Internal Medicine

Issue 4

2015 Issue 4

Most read in this issue

#ADS_BOTTOM_SCRIPTS#